Japan should fundamentally overhaul its cost-effectiveness assessment (CEA) scheme while putting a hold on CEA-based price adjustments, a new ruling…
HOME > REGULATORY
REGULATORY
- PAFSC First Committee on New Drugs to Discuss Approval of New Parkinson’s Disease Agent and DPP-4 Inhibitor Onglyza
March 5, 2013
- Health and Education Ministries along with Drug Makers to Start Intractable Disease Research using iPS Cells
March 5, 2013
- Lawmakers Organizing Non-Partisan Group to Break Deadlock on Establishment of 3rd-Party Drug Administration Watchdog Organization
March 5, 2013
- Generic Share by Volume Rose to 28.7% in September 2012, MHLW Reports
March 4, 2013
- Tokyo District Court Dismisses Takeda’s Actos Litigation Against 10 Companies; No Appeal Planned
March 4, 2013
- Japan’s Average Drug Price is 1.44 Times Higher than Europe: MHLW Tally
March 1, 2013
- MHLW’s Health and Medical Strategy HQ Aims to Draft a Final Plan by May
February 28, 2013
- Pharmacies’ Generic Drug Dispensing Rate Rises to 29.4%: Survey Reported to CSIMC
February 28, 2013
- 5 Years Too Long to Achieve Reference Generic Share Target of 60%: Bill Payer Reps at CSIMC Subcommittee
February 28, 2013
- Shuji Shirakawa of Kenporen Says Long-Listed Product Price Cuts Irrelevant to New Drug Development Premium
February 28, 2013
- Participation in TPP Talks “Will Not Damage” Japan’s Universal Health Insurance System: Health Minister Tamura
February 27, 2013
- PAFSC’s 2nd Committee Recommends Approval for CMIC’s Acute Porphyria Treatment
February 27, 2013
- JMACCT Revamps Database of Clinical Trial Institutions; Details Now Available Online
February 27, 2013
- MHLW Launches HQ to Promote Health and Medical Strategy
February 27, 2013
- Doctors' Average Monthly Wage Reaches 789,300 Yen in 2012, MHLW Survey Shows
February 25, 2013
- Govt Launches New Office of Health and Medical Strategy
February 25, 2013
- Ruling Parties’ Commission on Reduced Consumption Tax Rate System to Issue Interim Report This Summer
February 22, 2013
- MHLW Plans to Revise Ordinance within 2 to 3 Years to Allow Electronic Prescribing
February 22, 2013
- About 60% of Prefectures Won't Set Generic Share Targets in Medical Expenditure Optimization Plans
February 22, 2013
- MHLW to Examine Online OTC Drug Sales after Top Court Ruling
February 22, 2013
ページ
Global drug makers are forging ahead with therapies targeting lipoprotein(a), or Lp(a), a promising new approach to reducing cardiovascular risks.…
Japanese Prime Minister Sanae Takaichi said on October 14 that the government will consider the necessary measures for the FY2027…
Eli Lilly’s breast cancer drug Imulrio (imlunestrant) is finally joining Japan’s NHI price list on October 14, nearly 300 days…
The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…